Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


Novel gene therapy approach shows promise


Vanderbilt University Medical Center investigators are reporting success with a novel gene therapy approach. Working with cells grown in the laboratory, the group is the first to repair a defective gene and demonstrate that the resulting protein product is functional, said Dr. Alfred L. George Jr., senior author of a study published Dec. 15 in the Journal of Clinical Investigation.

Although use of the approach in patients is still years in the future, the findings are an important step in showing that a particular method of gene repair is possible, said George, director of Vanderbilt’s division of Genetic Medicine.

"We have very solid evidence that we can repair messenger RNA (the copy of DNA that is used to manufacture proteins), and that the repair results in a protein that has normalized function," he said. "That’s a good sign and makes us optimistic about moving forward with this type of gene therapy strategy."

Gene therapy is a phrase that describes many different modes of gene-based treatments. The most widely used strategy seeks to put normal copies of a gene into cells with a defective gene. An alternative approach targets a defective gene for repair, either of the DNA itself or of the messenger RNA copy of the gene -- the strategy favored by George’s group. Repairing messenger RNA offers advantages over other types of gene therapy, George said, because it works specifically in cells that have messenger RNA copies of the gene. Cells that are not actively using the targeted gene will not contain any messenger RNA copies to be repaired.

"We think this approach may have a niche. It could be useful for any inherited disease, but it may have a special ability to correct a problem in a dominant disorder, George said.

The RNA repair method studied by George and colleagues employs molecules called ribozymes -- repair machines that can be engineered to correct a defect in a selected messenger RNA. The current work targets for repair a mutation that causes myotonia congenita, an inherited muscle disease with symptoms including muscle stiffness. Because myotonia congenita is not a debilitating disease, gene therapy may not be appropriate for some patients, George said, but the disease serves as an excellent model for testing ribozymes as potential gene therapeutics.

"We know a great deal about myotonia congenita," George said. "We know about the genetics and the physiology, and we have cell culture and animal models. We have many experimental armaments to study the disease."

In addition, George said, myotonia congenita provides a good test case for more severe inherited muscle diseases, such as muscular dystrophy and related disorders.

Myotonia congenita is caused by mutations in chloride channels -- donut-like pores that allow chloride ions to pass across the cell membrane. Because chloride channels are important participants in the contraction-relaxation cycle of skeletal muscle, defects in these proteins affect muscle relaxation and cause muscle stiffness.

Over 80 different myotonia congenita-associated chloride channel mutations have been identified, George said. His team targeted one of these for repair, a mutation that George and colleagues first identified in a Pennsylvania dog named Sparky.

Dr. Christopher Rogers, a former graduate student in George’s laboratory, engineered ribozymes to correct the "Sparky" defect and then introduced the ribozymes into cells harboring the mutant chloride channels. He demonstrated that the ribozymes could indeed repair the messenger RNA for the defective channels and that the resulting repaired proteins had normal chloride channel function. The repair was not effective in all cells, George said, but in a small percentage of cells, chloride channel function was completely restored.

"We know now that the ribozyme method can work; it’s effective at producing a protein with completely normal function," George said. "It would be nice if we knew it worked in the dog, and that’s the next step."

The investigators will continue studies in cells to improve the efficiency of the method before they test it in a group of Sparky’s descendants -- a dog model of myotonia congenita.

Other contributors to the Journal of Clinical Investigation study include Drs. Carlos G. Vanoye and Bruce A. Sullenger. The work was supported by the National Institutes of Health and the Muscular Dystrophy Association.

Leigh MacMillan | EurekAlert!
Further information:

More articles from Health and Medicine:

nachricht Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg

nachricht New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>